MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash received for
sale of business, net
$363,222K
Proceeds from sales and
maturities of investments
$15,000K
Net cash provided by
investing activities
$191,090K
Effect of foreign
exchange rate...
$115K
Canceled cashflow
$187,132K
Net increase
(decrease) in cash, cash...
$144,568K
Canceled cashflow
$46,637K
Purchases of short-term
marketable debt securities
$127,208K
Purchases of long-term
marketable debt securities
$58,517K
Purchases of marketable
equity securities
$837K
Purchases of property and
equipment
$570K
Net income (loss)
$127,068K
Deferred tax asset,
non-current
$38,359K
Stock-based compensation
expense
$8,824K
Unrealized loss on equity
investments
-$3,494K
Inventory
-$1,935K
Depreciation and
amortization
$1,408K
Non-cash lease expense
$1,355K
Provision for excess and
obsolete inventory
$696K
Other non-cash items
$67K
Other liabilities
$1K
Proceeds from exercise of
stock options
$78K
Net cash used in
operating activities
-$46,597K
Net cash used in
financing activities
-$40K
Canceled cashflow
$183,207K
Canceled cashflow
$78K
Gain on sale of
business
$172,289K
Payments for taxes
related to net share...
$118K
Deferred revenue
-$29,934K
Accrued liabilities
-$20,785K
Accounts receivable, net
$1,858K
Prepaid expenses and
other assets
$1,592K
Operating lease
liabilities
-$1,490K
Accounts payable
-$1,224K
Accretion of discount on
short-term investments,...
$632K
Back
Back
Cash Flow
STANDARD BIOTOOLS INC. (LAB)
STANDARD BIOTOOLS INC. (LAB)
source: myfinsight.com